BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10749103)

  • 1. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.
    Radewicz K; Garey LJ; Gentleman SM; Reynolds R
    J Neuropathol Exp Neurol; 2000 Feb; 59(2):137-50. PubMed ID: 10749103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits.
    Garey L
    J Anat; 2010 Oct; 217(4):324-33. PubMed ID: 20408906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.
    Steiner J; Bielau H; Brisch R; Danos P; Ullrich O; Mawrin C; Bernstein HG; Bogerts B
    J Psychiatr Res; 2008 Jan; 42(2):151-7. PubMed ID: 17174336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.
    Wierzba-Bobrowicz T; Lewandowska E; Lechowicz W; Stepień T; Pasennik E
    Folia Neuropathol; 2005; 43(2):81-9. PubMed ID: 16012909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.
    Steiner J; Mawrin C; Ziegeler A; Bielau H; Ullrich O; Bernstein HG; Bogerts B
    Acta Neuropathol; 2006 Sep; 112(3):305-16. PubMed ID: 16783554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereological studies of capillary length density in the frontal cortex of schizophrenics.
    Kreczmanski P; Schmidt-Kastner R; Heinsen H; Steinbusch HW; Hof PR; Schmitz C
    Acta Neuropathol; 2005 May; 109(5):510-8. PubMed ID: 15886994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.
    Rajkowska G; Miguel-Hidalgo JJ; Makkos Z; Meltzer H; Overholser J; Stockmeier C
    Schizophr Res; 2002 Oct; 57(2-3):127-38. PubMed ID: 12223243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics.
    Garey LJ; Von Bussmann KA; Hirsch SR
    Exp Brain Res; 2006 Aug; 173(2):234-42. PubMed ID: 16505999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics.
    Wisniewski HM; Constantinidis J; Wegiel J; Bobinski M; Tarnawski M
    Alzheimer Dis Assoc Disord; 1994; 8(4):211-27. PubMed ID: 7888152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in glia and axons in the brains of Binswanger's disease patients.
    Akiguchi I; Tomimoto H; Suenaga T; Wakita H; Budka H
    Stroke; 1997 Jul; 28(7):1423-9. PubMed ID: 9227695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxigenin-tagged anti-GFAP and multiple labelling of human glia, vessels and beta-amyloid.
    Härtig W; Hausen D; Brauer K; Arendt T; Bigl V; Brückner G
    Neuroreport; 1994 Jan; 5(5):573-6. PubMed ID: 8025246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.
    Steffek AE; McCullumsmith RE; Haroutunian V; Meador-Woodruff JH
    Schizophr Res; 2008 Aug; 103(1-3):71-82. PubMed ID: 18562176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.
    Benes FM; Vincent SL; Marie A; Khan Y
    Neuroscience; 1996 Dec; 75(4):1021-31. PubMed ID: 8938738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients.
    Gos T; Myint AM; Schiltz K; Meyer-Lotz G; Dobrowolny H; Busse S; Müller UJ; Mawrin C; Bernstein HG; Bogerts B; Steiner J
    Brain Behav Immun; 2014 Oct; 41():59-64. PubMed ID: 24886967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia.
    Arnold SE; Franz BR; Trojanowski JQ; Moberg PJ; Gur RE
    Acta Neuropathol; 1996; 91(3):269-77. PubMed ID: 8834539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical intercorrelations of frontal area volumes in schizophrenia.
    Mitelman SA; Buchsbaum MS; Brickman AM; Shihabuddin L
    Neuroimage; 2005 Oct; 27(4):753-70. PubMed ID: 15990338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
    Broadbelt K; Jones LB
    J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics.
    Wierzba-Bobrowicz T; Lewandowska E; Kosno-Kruszewska E; Lechowicz W; Pasennik E; Schmidt-Sidor B
    Folia Neuropathol; 2004; 42(3):157-65. PubMed ID: 15535034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric analysis of microglia in Alzheimer's disease.
    Carpenter AF; Carpenter PW; Markesbery WR
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):601-8. PubMed ID: 8229079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.
    McGeer PL; Itagaki S; Tago H; McGeer EG
    Neurosci Lett; 1987 Aug; 79(1-2):195-200. PubMed ID: 3670729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.